SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000925
Filing Date
2022-04-15
Accepted
2022-04-15 09:06:51
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kprx-20211231x10k.htm   iXBRL 10-K 2424578
2 EX-21.1 kprx-20211231xex21d1.htm EX-21.1 4187
3 EX-23.1 kprx-20211231xex23d1.htm EX-23.1 5682
4 EX-31.1 kprx-20211231xex31d1.htm EX-31.1 11060
5 EX-32.1 kprx-20211231xex32d1.htm EX-32.1 6383
6 GRAPHIC kprx-20211231x10k006.jpg GRAPHIC 7843
7 GRAPHIC kprx-20211231x10k007.jpg GRAPHIC 14499
8 GRAPHIC kprx-20211231x10k010.jpg GRAPHIC 29024
9 GRAPHIC kprx-20211231x10k004.jpg GRAPHIC 21279
10 GRAPHIC kprx-20211231x10k011.jpg GRAPHIC 29118
11 GRAPHIC kprx-20211231x10k003.jpg GRAPHIC 39859
12 GRAPHIC kprx-20211231x10k002.jpg GRAPHIC 45115
13 GRAPHIC kprx-20211231x10k005.jpg GRAPHIC 9586
14 GRAPHIC kprx-20211231x10k009.jpg GRAPHIC 19036
15 GRAPHIC kprx-20211231x10k001.jpg GRAPHIC 39027
16 GRAPHIC kprx-20211231x10k008.jpg GRAPHIC 19109
  Complete submission text file 0001410578-22-000925.txt   8879608

Data Files

Seq Description Document Type Size
17 EX-101.SCH kprx-20211231.xsd EX-101.SCH 54403
18 EX-101.CAL kprx-20211231_cal.xml EX-101.CAL 71462
19 EX-101.DEF kprx-20211231_def.xml EX-101.DEF 214849
20 EX-101.LAB kprx-20211231_lab.xml EX-101.LAB 536079
21 EX-101.PRE kprx-20211231_pre.xml EX-101.PRE 403910
81 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20211231x10k_htm.xml XML 1145123
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36672 | Film No.: 22829125
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences